Dr. Megan Pendley Cooper received her Bachelor of Science degrees and Doctor of Pharmacy degree from the University of Kentucky. She then completed a PGY1 residency and academic fellowship at the University of Kentucky before becoming a clinic-based specialty pharmacist at the University of Kentucky in the Digestive Health Program.
Dr. Cooper specializes in the treatment of hepatitis C, providing comprehensive pharmaceutical care to patients at UK’s Digestive Health Program. She works directly with clinic providers and staff for prior authorizations, patient evaluation and education, and patient monitoring during and after treatment.
Dr. Cooper teaches at the UK College of Pharmacy and precepts students interested in ambulatory care in a specialized setting. Dr. Cooper provides lectures on hepatitis C treatment and patient care for public health, medical, and pharmacy groups around Kentucky in an effort to expand treatment opportunities for patients and to promote general understanding about hepatitis for providers and allied health professionals. The state of Kentucky leads the nation in hepatitis C cases, so Dr. Cooper and her team work daily to stem the epidemic where it is most virulent.
Faculty RankAdjunct Faculty, UK College of PharmacyAssistant Professor
PharmD, University of Kentucky, College of Pharmacy
PGY1 Community Pharmacy Residency, University of Kentucky, College of Pharmacy
Academic Fellow, University of Kentucky, College of Pharmacy
Certifications and Special Training
Kentucky Board of Pharmacy, Pharmacist
University of Kentucky, Scholarship of Teaching and Learning
American Pharmacists Association, Pharmacist and Patient-Centered Diabetes Care
American Pharmacists Association, Pharmacy-Based Travel Health Services
American Pharmacists Association, Medication Therapy Management
Professional Compounding Centers of America, Comprehensive Compounding Course
American Pharmacists Association, Pharmacy-Based Immunization Delivery
University of Kentucky, Human Subjects Research Protection Training Collaborative IRB Training Initiative (CITI)
American Heart Association, Basic Life Support
- Hepatitis C
- Hepatic encephalopathy
- Primary biliary cholangitis
Hepatitis C Update: Treatment, Interactions, Complications, Kentucky Society of Health-System Pharmacists 2018 Fall Meeting